Clinical Trial Update: Safety Study Evaluating Intravenous Infusions of Tigecycline to Treat Acute Myeloid Leukemia [Phase 1]

View source ↗

Summary

A Phase 1 safety study evaluating intravenous tigecycline for acute myeloid leukemia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Tigecycline (Tygacil) (tigecycline)

Snippet

Sponsor: University Health Network, Toronto | Conditions: Acute Myeloid Leukemia | Phase 1 | Status: COMPLETED